BMP15 suppresses progesterone production by down-regulating StAR via ALK3 in human granulosa cells

Molecular Endocrinology

Volumn 27, Issue 12, 2013, Pages 2093-2104

  Chang, Hsun Ming ^a   Cheng, Jung Chien ^a   Klausen, Christian ^a   Leung, Peter C K ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; BONE MORPHOGENETIC PROTEIN 15; BONE MORPHOGENETIC PROTEIN RECEPTOR 1A; CHOLESTEROL MONOOXYGENASE (SIDE CHAIN CLEAVING); GROWTH DIFFERENTIATION FACTOR 9; MESSENGER RNA; PROGESTERONE; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN; SMALL INTERFERING RNA; STEROIDOGENIC ACUTE REGULATORY PROTEIN;

ARTICLE; CONTROLLED STUDY; ENZYME SYNTHESIS; FEMALE; FEMALE FERTILITY; GRANULOSA CELL; GRANULOSA CELL TUMOR; HUMAN; HUMAN CELL; LUTEINIZATION; OOCYTE; OVARY FOLLICLE DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

BONE MORPHOGENETIC PROTEIN 15; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE I; CELL LINE; DOWN-REGULATION; FEMALE; GRANULOSA CELLS; GROWTH DIFFERENTIATION FACTOR 9; HUMANS; PHOSPHOPROTEINS; PHOSPHORYLATION; PROGESTERONE; PYRAZOLES; PYRIMIDINES; QUINOLINES; RNA, MESSENGER; SIGNAL TRANSDUCTION; SMAD PROTEINS;

EID: 84888379512     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2013-1233     Document Type: Article

References (49)

1. Juengel JL, McNatty KP. The role of proteins of the transforming growth factor-beta superfamily in the intraovarian regulation of follicular development. Hum Reprod Update. 2005;11:143-160.
2. Otsuka F, McTavish KJ, Shimasaki S. Integral role of GDF-9 and BMP-15 in ovarian function. Mol Reprod Dev. 2011;78:9-21.
3. Juengel JL, Bodensteiner KJ, Heath DA, et al. Physiology of GDF9 and BMP15 signalling molecules. Anim Reprod Sci. 2004;82-83: 447-460.
4. Aaltonen J, Laitinen MP, Vuojolainen K, et al. Human growth differentiation factor 9 (GDF-9) and its novel homolog GDF-9B are expressed in oocytes during early folliculogenesis. J Clin Endocrinol Metab. 1999;84:2744-2750.
5. Galloway SM, McNatty KP, Cambridge LM, et al. Mutations in an oocyte-derived growth factor gene (BMP15) cause increased ovulation rate and infertility in a dosage-sensitive manner. Nat Genet. 2000;25:279-283.
6. Hanrahan JP, Gregan SM, Mulsant P, et al. Mutations in the genes for oocyte-derived growth factors GDF9 and BMP15 are associated with both increased ovulation rate and sterility in Cambridge and Belclare sheep (Ovis aries). Biol Reprod. 2004;70:900-909.
7. Di Pasquale E, Beck-Peccoz P, Persani L. Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (BMP15) gene. Am J Hum Genet. 2004; 75:106-111.
8. Tiotiu D, Alvaro Mercadal B, Imbert R, et al. Variants of the BMP15 gene in a cohort of patients with premature ovarian failure. Hum Reprod. 2010;25:1581-1587.
9. Liu J, Wang B, Wei Z, et al. Mutational analysis of human bone morphogenetic protein 15 in Chinese women with polycystic ovary syndrome. Metabolism. 2011;60:1511-1514.
10. Montgomery GW, Zhao ZZ, Marsh AJ, et al. A deletion mutation in GDF9 in sisters with spontaneous DZ twins. Twin Res. 2004;7: 548-555.
11. Yan C, Wang P, DeMayo J, et al. Synergistic roles of bone morphogenetic protein 15 and growth differentiation factor 9 in ovarian function. Mol Endocrinol. 2001;15:854-866.
12. Otsuka F, Yao Z, Lee T, Yamamoto S, Erickson GF, Shimasaki S. Bone morphogenetic protein-15. Identification of target cells and biological functions. J Biol Chem. 2000;275:39523-39528.
13. Otsuka F, Yamamoto S, Erickson GF, Shimasaki S. Bone morphogenetic protein-15 inhibits follicle-stimulating hormone (FSH) action by suppressing FSH receptor expression. J Biol Chem. 2001; 276:11387-11392.
14. Otsuka F, Shimasaki S. A negative feedback system between oocyte bone morphogenetic protein 15 and granulosa cell kit ligand: its role in regulating granulosa cell mitosis. Proc Natl Acad Sci USA. 2002;99:8060-8065.
15. Wu YT, Tang L, Cai J, et al. High bone morphogenetic protein-15 level in follicular fluid is associated with high quality oocyte and subsequent embryonic development. HumReprod. 2007;22:1526-1531.
16. Yoshino O, McMahon HE, Sharma S, Shimasaki S. A unique preovulatory expression pattern plays a key role in the physiological functions of BMP-15 in the mouse. Proc Natl Acad Sci USA. 2006; 103:10678-10683.
17. Galloway SM, Gregan SM, Wilson T, et al. Bmp15 mutations and ovarian function. Mol Cell Endocrinol. 2002;191:15-18.
18. Shi FT, Cheung AP, Klausen C, Huang HF, Leung PC. Growth differentiation factor 9 reverses activin A suppression of steroidogenic acute regulatory protein expression and progesterone production in human granulosa-lutein cells. J Clin Endocrinol Metab. 2010;95:E172-180.
19. rd. Growth differentiation factor-9 inhibits 3'5'-adenosine monophosphate-stimulated steroidogenesis in human granulosa and theca cells. J Clin Endocrinol Metab. 2002;87:2849-2856.
20. Vitt UA, Hayashi M, Klein C, Hsueh AJ. Growth differentiation factor-9 stimulates proliferation but suppresses the follicle-stimulating hormone-induced differentiation of cultured granulosa cells from small antral and preovulatory rat follicles. Biol Reprod. 2000; 62:370-377.
21. Elvin JA, Clark AT, Wang P, Wolfman NM, Matzuk MM. Paracrine actions of growth differentiation factor-9 in the mammalian ovary. Mol Endocrinol. 1999;13:1035-1048.
22. Elis S, Dupont J, Couty I, et al. Expression and biological effects of bone morphogenetic protein-15 in the hen ovary. J Endocrinol. 2007;194:485-497.
23. Lie BL, Leung E, Leung PC, Auersperg N. Long-term growth and steroidogenic potential of human granulosa-lutein cells immortalized with SV40 large T antigen. Mol Cell Endocrinol. 1996;120: 169-176.
24. Kretzschmar M, Massagué J. SMADs: mediators and regulators of TGF-β signaling. Curr Opin Genet Dev. 1998;8:103-111.
25. Moore RK, Otsuka F, Shimasaki S. Molecular basis of bone morphogenetic protein-15 signaling in granulosa cells. J Biol Chem. 2003;278:304-310.
26. Mazerbourg S, Klein C, Roh J, et al. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5. Mol Endocrinol. 2004;18:653-665.
27. Shi FT, Cheung AP, Leung PC. Growth differentiation factor 9 enhances activin a-induced inhibin B production in human granulosa cells. Endocrinology. 2009;150:3540-3546.
28. Miyazono K, Kusanagi K, Inoue H. Divergence and convergence of TGF-β/BMP signaling. J Cell Physiol. 2001;187:265-276.
29. Hao J, Ho JN, Lewis JA, et al. In vivo structure-activity relationship study of dorsomorphin analogues identifies selective VEGF and BMP inhibitors. ACS Chem Biol. 2010;5:245-253.
30. Yu PB, Hong CC, Sachidanandan C, et al. Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. Nat Chem Biol. 2008;4:33-41.
31. Matzuk MM, Burns KH, ViveirosMM, Eppig JJ. Intercellular communication in the mammalian ovary: oocytes carry the conversation. Science. 2002;296:2178-2180.
32. Falck B. Site of production of oestrogen in rat ovary as studied in micro-transplants. Acta Physiol Scand Suppl. 1959;47:1-101.
33. el-Fouly MA, Cook B, Nekola M, Nalbandov AV. Role of the ovum in follicular luteinization. Endocrinology. 1970;87:286-293.
34. Dube JL, Wang P, Elvin J, Lyons KM, Celeste AJ, Matzuk MM. The bone morphogenetic protein 15 gene is X-linked and expressed in oocytes. Mol Endocrinol. 1998;12:1809-1817.
35. Orisaka M, Orisaka S, Jiang JY, et al. Growth differentiation factor 9 is antiapoptotic during follicular development from preantral to early antral stage. Mol Endocrinol. 2006;20:2456-2468.
36. Huang HY, Wang HS, Chan SH, Lee CL, Wang CW, Soong YK. Granulosa-lutein cell growth differentiation factor-9 (GDF-9) messenger RNA and protein expression in in vitro fertilization (IVF) cycles: relation to characteristics of ovulation induction and IVF. Fertil Steril. 2009;91:1583-1585.
37. Shi FT, Cheung AP, Huang HF, Leung PC. Effects of endogenous growth differentiation factor 9 on activin A-induced inhibin B production in human granulosa-lutein cells. J Clin Endocrinol Metab. 2009;94:5108-5116.
38. Wu YT, Wang TT, Chen XJ, et al. Bone morphogenetic protein-15 in follicle fluid combined with age may differentiate between successful and unsuccessful poor ovarian responders. Reprod Biol Endocrinol. 2012;10:116.
39. Gode F, Gulekli B, Dogan E, et al. Influence of follicular fluid GDF9 and BMP15 on embryo quality. Fertil Steril. 2011;95:2274-2278.
40. Hendarto H, Prabowo P, Moeloek FA, Soetjipto S. Growth differentiation factor 9 concentration in the follicular fluid of infertile women with endometriosis. Fertil Steril. 2010;94:758-760.
41. Mueller TD, Nickel J. Promiscuity and specificity in BMP receptor activation. FEBS Lett. 2012;586:1846-1859.
42. Pulkki MM, Mottershead DG, Pasternack AH, et al. A covalently dimerized recombinant human bone morphogenetic protein-15 variant identifies bone morphogenetic protein receptor type 1B as a key cell surface receptor on ovarian granulosa cells. Endocrinology. 2012;153:1509-1518.
43. Peng J, Li Q, Wigglesworth K, et al. Growth differentiation factor 9:bone morphogenetic protein 15 heterodimers are potent regulators of ovarian functions. Proc Natl Acad Sci USA. 2013;110: E776-E785.
44. Glister C, Kemp CF, Knight PG. Bone morphogenetic protein (BMP) ligands and receptors in bovine ovarian follicle cells: actions of BMP-4,-6 and-7 on granulosa cells and differential modulation of Smad-1 phosphorylation by follistatin. Reproduction. 2004;127: 239-254.
45. Pierre A, Pisselet C, Dupont J, Bontoux M, Monget P. Bone morphogenetic protein 5 expression in the rat ovary: biological effects on granulosa cell proliferation and steroidogenesis. Biol Reprod. 2005;73:1102-1108.
46. Shimasaki S, Zachow RJ, Li D, et al. A functional bone morphogenetic protein system in the ovary. Proc Natl Acad Sci USA. 1999; 96:7282-7287.
47. Otsuka F, Moore RK, Shimasaki S. Biological function and cellular mechanism of bone morphogenetic protein-6 in the ovary. J Biol Chem. 2001;276:32889-32895.
48. di Clemente N, Josso N, Gouédard L, Belville C. Components of the anti-Müllerian hormone signaling pathway in gonads. Mol Cell Endocrinol. 2003;211:9-14.
49. Kim JH, Seibel MM, MacLaughlin DT, et al. The inhibitory effects of müllerian-inhibiting substance on epidermal growth factor induced proliferation and progesterone production of human granulosa-luteal cells. J Clin Endocrinol Metab. 1992;75:911-917.